ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,431Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 154

$536K Total Retail Price of All Prescriptions

Rank: 2 out of 154

284 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 284 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 7,042 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $66 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
LISINOPRIL 566 386 1 1
SIMVASTATIN 556 471 2 3
METOPROLOL SUCCINATE 421 351 3 10
HYDROCHLOROTHIAZIDE 377 267 4 8
LEVOTHYROXINE SODIUM 376 307 5 2
OMEPRAZOLE 316 218 6 4
FUROSEMIDE 275 261 7 6
AMLODIPINE BESYLATE 239 190 8 7
CRESTOR 223 143 9 14
METFORMIN HCL 206 157 10 5
NEXIUM 145 83 11 12
LOSARTAN POTASSIUM 134 107 12 27
GLIMEPIRIDE 122 91 13 35
CITALOPRAM HBR 121 94 14 18
FAMOTIDINE 116 75 15 108
CLOPIDOGREL 116 86 15 22
PROAIR HFA 113 90 17 28
METOPROLOL TARTRATE 105 93 18 9
ADVAIR DISKUS 104 95 19 61
SERTRALINE HCL 103 43 20 15
PANTOPRAZOLE SODIUM 95 67 21 69
SINGULAIR 95 79 21 65
LISINOPRIL-HYDROCHLOROTHIAZIDE 93 64 23 53
ATORVASTATIN CALCIUM 92 68 24 17
METFORMIN HCL ER 92 61 24 64
SPIRIVA 89 71 26 42
DILTIAZEM 24HR ER 82 61 27 127
DIOVAN 81 66 28 58
LANTUS SOLOSTAR 73 52 29 93
FLUTICASONE PROPIONATE 72 34 30 34
GABAPENTIN 71 49 31 11
PLAVIX 71 57 31 43
HYDROCODONE-ACETAMINOPHEN 70 69 S3 33 23
POTASSIUM CHLORIDE 69 44 34 24
TRAMADOL HCL 68 38 35 13
KLOR-CON M10 65 37 36 138
AMLODIPINE BESYLATE-BENAZEPRIL 63 30 37 106
GLIPIZIDE 62 44 38 68
MONTELUKAST SODIUM 60 47 39 104
LOSARTAN-HYDROCHLOROTHIAZIDE 59 44 40 112
TRAMADOL HCL-ACETAMINOPHEN 58 55 41 146
TRIAMTERENE-HCTZ 56 31 42 117
PAROXETINE HCL 55 43 43 50
ALENDRONATE SODIUM 55 51 43 120
INSULIN SYRINGE 54 18 45 115
JANUVIA 54 40 45 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 5, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.